Newamsterdam Pharma Company N.V. (NAMS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NAMS | CRNX | AMRX | ||
| Company | Newamsterdam Pharma Company N.V. | Crinetics Pharmaceuticals Inc | Amneal Pharmaceuticals Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 35.29 | 49.78 | 12.47 | ||
| High | 35.92 | 50.19 | 12.52 | ||
| Low | 34.62 | 48.98 | 12.17 | ||
| Latest | 34.78 | 49.45 | 12.19 | ||
| Change | -0.57 | +0.13 | -0.27 | ||
| % Change | -1.61% | +0.26% | -2.17% | ||
| Volume | 469,140 | 314,325 | 562,436 | ||
| 20-Day Average Volume | 1,081,274 | 1,020,315 | 1,719,546 | ||
| Previous Close | 35.35 | 49.32 | 12.46 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 37.51 | 46.23 | 12.10 | ||
| 20-Day Raw Stochastic | 2.47% | 88.71% | 64.33% | ||
| 20-Day Relative Strength | 45.87 | 64.69 | 58.63 | ||
| Weighted Alpha | +65.58 | +10.03 | +68.84 | ||
| Today's Opinion | 56% Buy | 100% Buy | 100% Buy | ||
| Previous Opinion | 56% Buy | 100% Buy | 100% Buy | ||
| Last Month's Opinion | 100% Buy | 96% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.27% since 12/09/25 | +4.20% since 12/09/25 | +2.09% since 12/09/25 | ||
| Low | 34.62 on 12/16/25 | 47.43 on 12/10/25 | 11.86 on 12/10/25 | ||
| High | 37.41 on 12/15/25 | 50.98 on 12/12/25 | 12.53 on 12/15/25 | ||
| 1-Month | |||||
| %Chg | -9.50% since 11/14/25 | +16.97% since 11/14/25 | +4.98% since 11/14/25 | ||
| Low | 34.52 on 12/03/25 | 41.51 on 11/21/25 | 11.39 on 11/18/25 | ||
| High | 42.00 on 11/26/25 | 50.98 on 12/12/25 | 12.68 on 11/28/25 | ||
| 3-Month | |||||
| %Chg | +41.54% since 09/16/25 | +46.36% since 09/16/25 | +25.46% since 09/16/25 | ||
| Low | 24.36 on 09/17/25 | 33.28 on 09/19/25 | 9.49 on 09/25/25 | ||
| High | 42.00 on 11/26/25 | 50.98 on 12/12/25 | 12.68 on 11/28/25 | ||
| 6-Month | |||||
| %Chg | +75.72% since 06/16/25 | +59.97% since 06/16/25 | +50.68% since 06/16/25 | ||
| Low | 17.63 on 06/23/25 | 25.83 on 08/08/25 | 7.66 on 08/01/25 | ||
| High | 42.00 on 11/26/25 | 50.98 on 12/12/25 | 12.68 on 11/28/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 4,008,371 | 4,680,073 | 3,916,963 | ||
| Shares Outstanding, K | 113,391 | 94,892 | 314,363 | ||
| Annual Sales | 45,560,000 | 1,040,000 | 2,793,960,000 | ||
| Annual Net Income | -241,600,000 | -298,410,000 | -116,890,000 | ||
| Last Quarter Sales | 350,000 | 140,000 | 784,510,000 | ||
| Last Quarter Net Income | -72,010,000 | -130,090,000 | 2,370,000 | ||
| 60-Month Beta | 0.05 | 0.20 | 1.36 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.41 on 11/05/25 | -1.38 on 11/06/25 | 0.17 on 10/30/25 | ||
| Latest Earnings Date | 02/25/26 | 02/26/26 | 02/27/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 18.22 | ||